We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says CytoDyn’s HIV Drug Leronlimab Shows No Benefit for COVID-19
FDA Says CytoDyn’s HIV Drug Leronlimab Shows No Benefit for COVID-19
The FDA refuted CytoDyn’s claims about the efficacy of the company’s experimental HIV drug leronlimab as a COVID-19 treatment based on data from two late-stage trials.